Did Josh Gottheimer buy Halozyme Therapeutics stock?

Common questions

Did Josh Gottheimer buy Halozyme Therapeutics stock?

Yes. Josh Gottheimer disclosed 2 purchases and 3 sales of Halozyme Therapeutics (HALO) stock between Oct 19, 2020 and Sep 9, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $3K-$45K.

How big were Josh Gottheimer's Halozyme Therapeutics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $2K-$30K and the disclosed sales to $3K-$45K.

Did Josh Gottheimer make these Halozyme Therapeutics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Josh Gottheimer still own Halozyme Therapeutics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Josh Gottheimer report these trades?

The latest filing is dated Oct 3, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.